SAGE – Sage Therapeutics, Inc.
Sage Therapeutics, Inc.SAGE
$8.68Name : Sage Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $544,942,592.00
EPSttm : -4.89
Sage Therapeutics, Inc.
$8.68
0.00%$0.0000Float Short %
4.02
Margin Of Safety %
Put/Call OI Ratio
0.92
EPS Next Q Diff
-0.07
EPS Last/This Y
2.98
EPS This/Next Y
0.46
Price
8.68
Target Price
9.08
Analyst Recom
3
Performance Q
14.21
Relative Volume
Beta
0.26
Ticker: SAGE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-04 | SAGE | 9.2 | 0.68 | 0.58 | 34985 |
| 2025-07-07 | SAGE | 9.17 | 0.68 | 0.11 | 35259 |
| 2025-07-08 | SAGE | 9.16 | 0.68 | 0.90 | 36014 |
| 2025-07-09 | SAGE | 9.2 | 0.68 | 0.30 | 36041 |
| 2025-07-10 | SAGE | 9.2 | 0.67 | 0.00 | 36406 |
| 2025-07-11 | SAGE | 9.26 | 0.62 | 0.35 | 38417 |
| 2025-07-14 | SAGE | 9.16 | 0.61 | 1.59 | 38540 |
| 2025-07-15 | SAGE | 9.17 | 0.63 | 0.01 | 38901 |
| 2025-07-16 | SAGE | 9.14 | 0.60 | 0.00 | 40061 |
| 2025-07-17 | SAGE | 9.15 | 0.61 | 0.09 | 39763 |
| 2025-07-18 | SAGE | 9.11 | 0.61 | 0.01 | 39771 |
| 2025-07-21 | SAGE | 8.98 | 0.66 | 1.32 | 35287 |
| 2025-07-22 | SAGE | 8.76 | 0.66 | 0.80 | 35537 |
| 2025-07-23 | SAGE | 8.77 | 0.67 | 6.28 | 36832 |
| 2025-07-24 | SAGE | 8.77 | 0.69 | 61.74 | 37776 |
| 2025-07-25 | SAGE | 8.81 | 0.75 | 2.53 | 39007 |
| 2025-07-28 | SAGE | 8.78 | 0.75 | 0.33 | 39055 |
| 2025-07-29 | SAGE | 8.7 | 0.80 | 9.92 | 37641 |
| 2025-07-30 | SAGE | 8.68 | 0.92 | 0.01 | 39667 |
| 2025-07-31 | SAGE | 8.68 | 0.92 | 0.21 | 39667 |
| 2025-08-01 | SAGE | 8.68 | 0.92 | 0.21 | 39667 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-04 | SAGE | 9.20 | 44.5 | - | -3.61 |
| 2025-07-07 | SAGE | 9.17 | 44.5 | - | -3.61 |
| 2025-07-08 | SAGE | 9.16 | 44.5 | - | -3.61 |
| 2025-07-09 | SAGE | 9.20 | 44.5 | - | -3.61 |
| 2025-07-10 | SAGE | 9.21 | 44.5 | - | -3.61 |
| 2025-07-11 | SAGE | 9.27 | 44.5 | - | -3.61 |
| 2025-07-14 | SAGE | 9.15 | 44.5 | - | -3.61 |
| 2025-07-15 | SAGE | 9.17 | 44.5 | - | -3.61 |
| 2025-07-16 | SAGE | 9.14 | 44.5 | - | -3.61 |
| 2025-07-17 | SAGE | 9.14 | 44.5 | - | -3.61 |
| 2025-07-18 | SAGE | 9.12 | 44.5 | - | -3.61 |
| 2025-07-21 | SAGE | 8.97 | 44.5 | - | -3.61 |
| 2025-07-22 | SAGE | 8.75 | 44.5 | - | -3.61 |
| 2025-07-23 | SAGE | 8.77 | 44.5 | - | -3.61 |
| 2025-07-24 | SAGE | 8.76 | 44.5 | - | -3.61 |
| 2025-07-25 | SAGE | 8.80 | 44.5 | - | -3.61 |
| 2025-07-28 | SAGE | 8.79 | 44.5 | - | -3.61 |
| 2025-07-29 | SAGE | 8.70 | 44.5 | - | -3.61 |
| 2025-07-30 | SAGE | 8.68 | 44.5 | - | -3.61 |
| 2025-07-31 | SAGE | 8.68 | 44.5 | - | -3.61 |
| 2025-08-01 | SAGE | 8.68 | 44.5 | - | -3.61 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-04 | SAGE | 0.00 | -6.58 | 9.53 |
| 2025-07-07 | SAGE | 0.00 | -6.62 | 9.53 |
| 2025-07-08 | SAGE | 0.00 | -6.62 | 9.53 |
| 2025-07-09 | SAGE | 0.00 | -6.62 | 9.53 |
| 2025-07-10 | SAGE | 0.00 | -6.62 | 9.53 |
| 2025-07-11 | SAGE | 0.00 | -6.62 | 5.09 |
| 2025-07-14 | SAGE | 0.00 | -6.53 | 5.09 |
| 2025-07-15 | SAGE | 0.00 | -6.53 | 5.09 |
| 2025-07-16 | SAGE | 0.00 | -6.53 | 5.09 |
| 2025-07-17 | SAGE | 0.00 | -6.53 | 5.09 |
| 2025-07-18 | SAGE | 0.00 | -6.53 | 5.09 |
| 2025-07-21 | SAGE | 0.00 | -6.58 | 5.09 |
| 2025-07-22 | SAGE | 0.00 | -6.58 | 5.09 |
| 2025-07-23 | SAGE | 0.00 | -6.58 | 5.09 |
| 2025-07-24 | SAGE | 0.00 | -6.58 | 5.09 |
| 2025-07-25 | SAGE | 0.00 | -6.58 | 4.02 |
| 2025-07-28 | SAGE | 0.00 | -6.90 | 4.02 |
| 2025-07-29 | SAGE | 0.00 | -6.90 | 4.02 |
| 2025-07-30 | SAGE | 0.00 | -6.90 | 4.02 |
| 2025-07-31 | SAGE | 0.00 | -6.90 | 4.02 |
| 2025-08-01 | SAGE | 0.00 | -6.90 | 4.02 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.79
Avg. EPS Est. Current Quarter
-0.94
Avg. EPS Est. Next Quarter
-0.86
Insider Transactions
Institutional Transactions
-6.9
Beta
0.26
Average Sales Estimate Current Quarter
16
Average Sales Estimate Next Quarter
24
Fair Value
Quality Score
33
Growth Score
44
Sentiment Score
38
Actual DrawDown %
91.2
Max Drawdown 5-Year %
-95.1
Target Price
9.08
P/E
Forward P/E
PEG
P/S
7.72
P/B
1.47
P/Free Cash Flow
EPS
-4.89
Average EPS Est. Cur. Y
-3.61
EPS Next Y. (Est.)
-3.16
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-427.77
Relative Volume
Return on Equity vs Sector %
-105.4
Return on Equity vs Industry %
-86.8
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sage Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 353
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. The company offers ZURZUVAE, a neuroactive steroid positive allosteric modulator of GABA receptors targeting synaptic and extrasynaptic GABA receptors for the treatment of postpartum depression in adults. Its product pipeline also includes SAGE-324, a novel GABA receptor positive allosteric modulator for chronic oral dosing, including seizures in developmental and epileptic encephalopathies; and SAGE-319, an extrasynaptic-preferring GABA receptor positive allosteric modulator PAM for treating behavioral symptoms associated with neurodevelopmental disorders. In addition, the company is developing various product candidates, including SAGE-817 and SAGE-039 for the treatment of acute and chronic brain health disorders, including work on allosteric modulation of the GABA and NMDA receptor systems in the brain, as well as NMDA receptor negative allosteric modulator focusing on the treatments for neurodevelopmental disorders. The company was formerly known as Sterogen Biopharma, Inc. and changed its name to Sage Therapeutics, Inc. in September 2011. Sage Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. As of July 31, 2025, Sage Therapeutics, Inc. operates as a subsidiary of Saphire, Inc.
stock quote shares SAGE – Sage Therapeutics, Inc. Stock Price stock today
news today SAGE – Sage Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch SAGE – Sage Therapeutics, Inc. yahoo finance google finance
stock history SAGE – Sage Therapeutics, Inc. invest stock market
stock prices SAGE premarket after hours
ticker SAGE fair value insiders trading